TCT 2024 - TCTMD.com
2024年10月27日 · TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting the next wave of innovation in research and education that will help doctors save and improve the quality of their patients’ lives.
TCTMD - tctmd.com
TCTMD: the most comprehensive online resource for interventional cardiology and beyond, with news coverage spanning the entire field of cardiovascular disease.
What’s Going to Be Big at TCT 2024? | tctmd.com
2024年10月17日 · TCT 2024, the annual scientific showcase of interventional cardiovascular medicine, is returning once again to Washington, DC. The 4-day meeting starts Sunday, October 27, 2024, and will involve more than 1,400 faculty spread out across 161 different sessions, including 33 live endovascular, structural, and coronary cases. Three sessions, one per day, will deliver 11 late-breaking clinical ...
Cheaper Version of Tirzepatide for Weight Loss Now Available, …
2024年8月28日 · The manufacturer is selling single-dose vials of the drug via its online pharmacy at around $400 to $500 for a 4-week supply.
Amit Goyal, MD | tctmd.com
2024年12月30日 · Amit Goyal, MD, is a structural interventional cardiologist and Director of the CICU at the Dallas VA Medical Center, Editor-in-Chief of US Cardiology Review, and co-founder —with Daniel Ambinder, MD— of CardioNerds.. In the latter capacity, he leads the overarching curriculum and has designed the CardioNerds Clinical Trials Network, CardioNerds Academy, and Medical Journalism programs.
QFR No Match for FFR in Guiding Revascularizations: FAVOR III …
2024年10月30日 · WASHINGTON, DC—As a guide for deciding whether to revascularize patients with intermediate coronary stenoses, quantitative flow ratio (QFR) isn’t able to match fractional flow reserve (FFR) in terms of 12-month clinical outcomes, data from the large, randomized, FAVOR III Europe trial show.
PEERLESS: FlowTriever Tops Catheter-Directed Thrombolysis for …
2024年10月29日 · WASHINGTON, DC—In PEERLESS, the first randomized controlled trial pitting two different interventional strategies against each other in pulmonary embolism (PE), patients with acute intermediate-risk PE fared better over the short term if they received large-bore mechanical thrombectomy with the FlowTriever system (Inari Medical) rather than catheter-directed thrombolysis.
AHA 2024 | tctmd.com
TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting the next wave of innovation in research and education that will help doctors save and improve the quality of their patients’ lives.
The BUDAPEST CRT Upgrade Trial | tctmd.com
Béla Merkely and C. Michael Gibson discuss the results of a CRT-D upgrade versus ICD alone for HFrEF patients with right ventricular pacing.
Will Semaglutide Change Cardiac Surgery? It Already Has
2024年10月10日 · LISBON, Portugal—One of the first presentations at Europe’s annual cardiothoracic surgery conference was not about a new technique or device, but whether the revolutionary obesity medications targeting the glucagon-like peptide-1 (GLP-1) receptor will change the landscape of surgical practice.